Navigation Links
Nano3D Biosciences Releases 96-well BioAssembler for 3D Cell Culture
Date:2/12/2013

Houston, TX (PRWEB) February 12, 2013

Nano3D BiosciencesTM (n3D), a company that specializes in three-dimensional (3D) cell culturing technology for the drug discovery, toxicology, and life science research markets, announces the release of its 24-well Bio-AssemblerTM.

"The release of our 96-well BioAssembler is another step forward in our ever increasing offering of 3D cell culture products using our proprietary magnetic levitation cell culture technology. The 96 well format will allow greater throughput and lend itself to laboratory automation technologies which will be of great benefit to high throughput drug screening and toxicity studies," said Chief Scientific Officer Dr. Glauco Souza.

The Bio-AssemblerTM promotes the development and growth of 3D cellular structures through magnetic levitation. It uses a proprietary nanoparticle-based assembly called “Nanoshuttle-PL” to deliver magnetic nanoparticles to the cells. Preparation time and cell manipulation are very similar to that of 2D cell culture or conventional cell culturing methods, with the end result allowing for a more accurate representation of in vivo tissue. The technology is compatible with any media, diagnostic technique or cell type. The company now offers 96, 24, 6 and single well formats. These products are available from MIDSCI in the US, Funakoshi in Japan, Novusci in the UK and directly from n3D.

n3D is proud to bring its groundbreaking solutions for 3D cell culturing to the drug discovery, toxicology, and life science research markets.

About n3D Biosciences
n3D is the award recipient of the Texas Emerging Technology Fund (TETF), National Science Foundation SBIR (Phase I and Phase II) awards, and the Goradia Innovation Prize. Located in Houston, TX this highly innovative biotech start-up is already making waves in the Biotechnology and Nanotechnology industry. The company has been featured in Nature Nanotechnology and MIT Technology Review (Bio-Assembling in 3-D with Magnetic Levitation - Technology Review) for its state-of-the-art 3D cell culturing technology.

Read the full story at http://www.prweb.com/releases/n3dbiosciences/newproduct/prweb10420438.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
2. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
3. Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
4. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
5. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
6. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
7. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
8. Sangamo BioSciences Announces Fourth Quarter and Full Year 2011 Conference Call and Webcast
9. Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference
10. Ambit Biosciences to Present at Two Upcoming Investor Conferences
11. GeneLink Biosciences Completes Sale of GeneWize Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... 5, 2016 Australian-US drug discovery and development company, ... appointment of a new Chairman, Mr John O,Connor , ... immediately. James Garner , has also been ... former Acting CEO, Mr Iain Ross , will resume ... --> James Garner , has also been formally appointed ...
(Date:2/4/2016)... (PRWEB) , ... February 04, 2016 , ... ... latest GC-MS and triple quad LC-MS, host live demos and poster sessions, and ... conference and exhibition. The conference takes place March 6 to 10 at the ...
(Date:2/4/2016)... and MENLO PARK, Calif. , Feb. 4, ... and the "Company"), a biopharmaceutical company focused on the development ... will present at the 18 th Annual BIO ... at 10:00 a.m. EST in New York, NY ... and CEO, will provide an update on the ongoing clinical ...
(Date:2/4/2016)... Sinovac Biotech Ltd. ("Sinovac" or the "Company") ... products in China , today announced ... received on February 4, 2016 a preliminary non-binding proposal ... of PKU V-Ming ( Shanghai ) Investment ... Development ( Shenzhen ) Fund Management Co., ...
Breaking Biology Technology:
(Date:2/4/2016)... , Feb. 4, 2016 The field ... one of the most popular hubs of the ... and other huge studies of human microbiota, have ... few years, the microbiome space has literally exploded ... research. This report focuses on biomedical aspects ...
(Date:2/2/2016)... , Feb. 2, 2016  BioMEMS ... are primarily focused on medical screening and ... point-of-care parameters. Wearable devices that facilitate and ... freedom of movement are being bolstered through ... human biomedical signal acquisition coupled with wireless ...
(Date:2/2/2016)... 2, 2016  Based on its recent analysis ... recognizes US-based Intelligent Retinal Imaging Systems (IRIS) with ... for New Product Innovation. IRIS, a prominent cloud-based ... America , is poised to set the ... retinopathy market. The IRIS technology presents superior price-performance ...
Breaking Biology News(10 mins):